transplant

(redirected from Transplant rejection)
Also found in: Dictionary, Thesaurus, Medical, Legal, Wikipedia.

transplant

Surgery
a. the procedure involved in such a transfer
b. the organ or tissue transplanted
References in periodicals archive ?
The company said Clazakizumab is a humanized, monoclonal antibody that binds to and inhibits Interleukin-6 (IL-6), which is an important driver of the inflammatory response and is known to play a key role in transplant rejection.
They also believe that this test could detect heart and kidney transplant rejection, and are conducting additional studies to confirm this.
Further studies will evaluate the effect of vitamin D therapy on short- and long-term lung transplant rejection rates, lung function and long-term survival.
AlloMap is a simple, non-invasive blood test that aids physicians in evaluating the risk for heart transplant rejection.
M2 PHARMA-November 19, 2014-Researchers develop non-invasive test capable of identifying patients at risk of kidney transplant rejection
According to the company, AAT (Alpha-1 Antitrypsin) is used in reducing the risk of a non-organ transplant rejection, reducing the risk of developing graft versus host disease (GvHD) and for treating GvHD in patients who have received a cornea, bone marrow, stem cell or pancreatic islet cell transplant.
XDx, Brisbane, CA, announced that Blue Shield ofCalifornia considers AlloMap "medically necessary" for monitoring heart transplant rejection more than one-year post-transplant.
develops anticancer therapies and treatments for cancer therapy-related bone-marrow suppression and for the management of transplant rejection.
The drug, which is currently undergoing clinical trials in the United States and Europe, is intended for the noninvasive diagnosis of cardiac transplant rejection.
Roberts of John Radcliffe Hospital in Oxford, England, suggests that finding a mechanism for disabling dendritic cells might prove useful against autoimmune diseases, could help in suppressing transplant rejection, or may aid in combating graft-versus-host disease--in which immune cells in transplanted tissue attack the recipient's cells.
A new test for heart transplant rejection that relies on simple blood tests rather than invasive and risky cardiac biopsies conventionally used to detect rejection has been developed by researchers at Stanford University.